September 20, 2023
September 20, 2023 —
To advance research and patient care for those suffering from lupus, William J. Wolfe and his family have donated $1.6 million to establish the Wolfe Lupus Research Fund at UC San Diego.
May 12, 2021
May 12, 2021 —
Researchers at UC San Diego School of Medicine have begun a pilot clinical trial to test the efficacy of using ultrasound to stimulate the spleen and reduce COVID-19-related inflammation, decreasing the length of hospital stays.
November 23, 2020
November 23, 2020 —
While respiratory issues continue to be the most common symptom of a COVID-19 infection, new research indicates the disease could also be associated with an increased tendency of the blood to clot, leading to a higher risk of death from COVID-19.
December 5, 2023
December 5, 2023 —
UC San Diego Health has once again been recognized as a High Performing Hospital for Obstetric and Infant Care by U.S. News & World Report.
November 24, 2021
November 24, 2021 —
The California Institute for Regenerative Medicine (CIRM) approved a $4.1 million grant to enable University of California San Diego School of Medicine researchers to advance a new chimeric antigen receptor (CAR) T-cell therapy from the laboratory into the clinic.
July 15, 2024
July 15, 2024 —
Region’s only academic health system ranks No. 1 in San Diego and California with 11 medical and surgical specialties rated among nation’s best.
July 20, 2023
July 20, 2023 —
The ceremony recognized the work of individuals and teams whose improvement projects made a positive impact for providers, staff and patients at UC San Diego Health.
September 16, 2022
September 16, 2022 —
UC San Diego study finds housing instability linked to increased mortality risk in cancer, highlighting need to screen for patients’ social risk factors
January 11, 2018
January 11, 2018 —
…member of the UC San Diego Health Cancer Network, patients of Eisenhower Health will have enhanced access to world-class cancer care, both at Eisenhower Lucy Curci Cancer Center and at UC San Diego Health.
December 6, 2018
December 6, 2018 —
Researchers find that patients with severe, refractory schizophrenia benefit from targeted cognitive therapy, improving auditory and verbal outcomes and the way they process information.